四川九洲(000801.SZ):控股子公司已利用現有消費級AI算力資源完成DeepSeek-R1-32B/70B模型本地部署
格隆匯3月13日丨四川九洲(000801.SZ)於投資者互動平臺表示,公司控股子公司已利用現有消費級AI算力資源完成DeepSeek-R1-32B/70B模型本地部署,目前主要用於產品開發與測試驗證、垂直大模型的訓練及應用研究等,通過DeepSeek的部署降低了建設相關專業領域大模型的成本,同時通過AI賦能,提升了產品技術水平和開發效率,後續公司將圍繞工藝優化與良率提升、智能質檢與缺陷分析、供應鏈與生產調度優化、工業知識管理與輔助研發設計、人機協作與工人賦能、文檔處理與智能辦公等方向探索更多的應用方向。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.